EUVIMEDEUVIMED entdecken
Crossref

Environmental risk of clinical selective serotonin reuptake inhibitors (SSRIs): Toxic effects of sertraline and fluoxetine on the freshwater fish

Vishal Rajput, Khusi Saraswat, Pooja Sajwan, Kanak Verma, Manish Tenguria, Avnish Chauhan, Vivek Kumar

Drug Discovery and Development · 09.06.2026 · 2 (2) · 1-9

DOI: 10.5530/ddd.2.2.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Discovery and Development, online erschienen am 09.06.2026. Verfasst von Vishal Rajput und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rajput, V., Saraswat, K., Sajwan, P., Verma, K., Tenguria, M., Chauhan, A., & Kumar, V. (2026). Environmental risk of clinical selective serotonin reuptake inhibitors (SSRIs): Toxic effects of sertraline and fluoxetine on the freshwater fish. Drug Discovery and Development, 2(2), 1-9. https://doi.org/10.5530/ddd.2.2.8

Vancouver

Rajput V, Saraswat K, Sajwan P, Verma K, Tenguria M, Chauhan A, et al. Environmental risk of clinical selective serotonin reuptake inhibitors (SSRIs): Toxic effects of sertraline and fluoxetine on the freshwater fish. Drug Discovery and Development. 2026;2(2):1-9. doi:10.5530/ddd.2.2.8

BibTeX
@article{Rajput2026,
  author = {Rajput, Vishal and Saraswat, Khusi and Sajwan, Pooja and Verma, Kanak and Tenguria, Manish and Chauhan, Avnish and Kumar, Vivek},
  title = {Environmental risk of clinical selective serotonin reuptake inhibitors (SSRIs): Toxic effects of sertraline and fluoxetine on the freshwater fish},
  journal = {Drug Discovery and Development},
  year = {2026},
  volume = {2},
  number = {2},
  pages = {1--9},
  doi = {10.5530/ddd.2.2.8}
}
Kostenlos starten →